AssetMark Inc
EBS icon

AssetMark Inc’s Emergent Biosolutions EBS Stock Holding History

AssetMark Inc’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-639
Closed -$32K – 1541
2021
Q3 		$32K Hold
639
– – ﹤0.01% 861
2021
Q2 		$40K Sell
639
-449
-41% -$28.8K ﹤0.01% 785
2021
Q1 		$101K Buy
1,088
+408
+60% +$41.8K ﹤0.01% 628
2020
Q4 		$61K Sell
680
-6
-0.9% -$551 ﹤0.01% 678
2020
Q3 		$71K Buy
686
+268
+64% +$28.9K ﹤0.01% 626
2020
Q2 		$33K Buy
+418
New +$31.1K ﹤0.01% 716
2019
Q3 		– Sell
-143
Closed -$7K – 1328
2019
Q2 		$7K Buy
143
+33
+30% +$1.58K ﹤0.01% 1010
2019
Q1 		$6K Buy
110
+19
+21% +$1.12K ﹤0.01% 1042
2018
Q4 		$5K Sell
91
-61
-40% -$3.93K ﹤0.01% 1090
2018
Q3 		$10K Sell
152
-14
-8% -$817 ﹤0.01% 1045
2018
Q2 		$8K Sell
166
-9
-5% -$469 ﹤0.01% 1080
2018
Q1 		$9K Buy
175
+6
+4% +$299 ﹤0.01% 1063
2017
Q4 		$8K Buy
169
+167
+8,350% +$7.03K ﹤0.01% 1151
2017
Q3 		$0 Hold
2
– – ﹤0.01% 1497
2017
Q2 		$0 Hold
2
– – ﹤0.01% 1392
2017
Q1 		$0 Sell
2
-14
-88% -$426 ﹤0.01% 1304
2016
Q4 		$1K Buy
16
+14
+700% +$420 ﹤0.01% 1183
2016
Q3 		$0 Hold
2
– – ﹤0.01% 1222
2016
Q2 		$0 Hold
2
– – ﹤0.01% 1193
2016
Q1 		$0 Sell
2
-7,335
-100% -$259K ﹤0.01% 1229
2015
Q4 		$294K Sell
7,337
-278
-4% -$9.69K 0.01% 387
2015
Q3 		$217K Sell
7,615
-3,285
-30% -$108K ﹤0.01% 326
2015
Q2 		$359K Sell
10,900
-899
-8% -$27.9K 0.01% 389
2015
Q1 		$339K Buy
+11,799
New +$338K 0.01% 377

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AssetMark Inc's EBS Position: Q4 2021 in Review

AssetMark Inc sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 639 shares — an estimated $32K sold.

AssetMark Inc first reported a position in EBS in Q1 2015 and held it in 24 quarters. The position peaked at $359K in Q2 2015. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • AssetMark Inc reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • AssetMark Inc sold 639 Emergent Biosolutions shares in Q4 2021, an estimated $32K.
  • AssetMark Inc first reported a position in Emergent Biosolutions in Q1 2015 and held it in 24 quarters.
  • AssetMark Inc's Emergent Biosolutions position peaked at $359K in Q2 2015.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on AssetMark Inc's 13F filing for Q4 2021, filed 14 Feb 2022.